{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:13:34Z","timestamp":1759342414179,"version":"build-2065373602"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.revmed.2012.12.005","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T16:02:39Z","timestamp":1357920159000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effets ind\u00e9sirables m\u00e9taboliques et cardiovasculaires des corticoth\u00e9rapies syst\u00e9miques"],"prefix":"10.1016","volume":"34","author":[{"given":"L.","family":"Fardet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.12.005_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.revmed.2012.12.005_bib0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00125-011-2174-9","article-title":"Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial","volume":"54","author":"van Raalte","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.revmed.2012.12.005_bib0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ophtha.2004.10.032","article-title":"Short-term tolerance of pulse methylprednisolone therapy in patients with diabetes mellitus","volume":"112","author":"Feldman-Billard","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1525-1497.2002.10649.x","article-title":"Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly","volume":"17","author":"Blackburn","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archinte.1994.00420010131015","article-title":"Glucocorticoids and the risk for initiation of hypoglycemic therapy","volume":"154","author":"Gurwitz","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0040","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2012.12.005_bib0045","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.005_bib0050","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198709000-00010","article-title":"The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients","volume":"44","author":"Boudreaux","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2012.12.005_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1464-5491.2000.00206.x","article-title":"Predicting the occurrence of diabetes mellitus in recipients of heart transplants","volume":"17","author":"Depczynski","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0060","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000166932","article-title":"Posttransplant diabetes in kidney transplant recipients","volume":"5","author":"Friedman","year":"1985","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0029-7844(97)00544-9","article-title":"Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery","volume":"90","author":"Fisher","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0070","first-page":"259","article-title":"Risk factors for steroid diabetes in rheumatic patients","volume":"29","author":"Ra\u00fal Ariza-Andraca","year":"1998","journal-title":"Arch Med Res"},{"key":"10.1016\/j.revmed.2012.12.005_bib0075","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.arcmed.2006.05.004","article-title":"Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients","volume":"37","author":"Andrade-Sierra","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1016\/j.revmed.2012.12.005_bib0085","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2012.12.005_bib0090","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0961203311402246","article-title":"Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy","volume":"20","author":"Ha","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2012.12.005_bib0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3346\/jkms.2011.26.2.264","article-title":"Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease","volume":"26","author":"Kim","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.revmed.2012.12.005_bib0100","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000097598","article-title":"Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases","volume":"105","author":"Uzu","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.revmed.2012.12.005_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00191902","article-title":"Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man","volume":"46","author":"Bruno","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00542555","article-title":"Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects","volume":"22","author":"Pagano","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0115","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.33378","article-title":"Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction","volume":"64","author":"den Uyl","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.005_bib0120","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","article-title":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD","volume":"96","author":"Burt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0125","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/kes003","article-title":"Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study","volume":"51","author":"Burt","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.12.005_bib0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2265.2011.04242.x","volume":"77","author":"Yuen","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.revmed.2012.12.005_bib0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","article-title":"Diabetes in Cushing syndrome: basic and clinical aspects","volume":"22","author":"Mazziotti","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000314316","article-title":"Management of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Munir","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc10-1677","article-title":"Glucagon-like peptide-1\u00a0receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans","volume":"34","author":"van Raalte","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2012.12.005_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/diacare.6.1.23","article-title":"Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy","volume":"6","author":"Arner","year":"1983","journal-title":"Diabetes Care"},{"key":"10.1016\/j.revmed.2012.12.005_bib0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/oxfordjournals.ndt.a092140","article-title":"High incidence of post-transplant diabetes mellitus in a single-centre study","volume":"7","author":"Onwubalili","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2012.12.005_bib0160","first-page":"S48","article-title":"Early steroid withdrawal in liver transplantation is safe and beneficial","volume":"5","author":"Everson","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.revmed.2012.12.005_bib0165","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00007890-199102000-00020","article-title":"Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients","volume":"51","author":"Hricik","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2012.12.005_bib0170","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000145435.80005.1E","article-title":"Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal","volume":"15","author":"Midtvedt","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing's syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0180","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.revmed.2012.12.005_bib0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.2.5858.85","article-title":"Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy","volume":"2","author":"el-Shaboury","year":"1973","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2012.12.005_bib0190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/pgmj.56.657.491","article-title":"Corticosteroid treatment, serum lipids and coronary artery disease","volume":"56","author":"Jefferys","year":"1980","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.revmed.2012.12.005_bib0195","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/art.21329","article-title":"Glucocorticoid use and serum lipid levels in US adults: the Third National Health and Nutrition Examination Survey","volume":"53","author":"Choi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.005_bib0200","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0026-0495(84)90006-4","article-title":"The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: a prospective study","volume":"33","author":"Zimmerman","year":"1984","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.revmed.2012.12.005_bib0205","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1210\/jc.2004-2379","article-title":"Effects of short-term glucocorticoids on cardiovascular biomarkers","volume":"90","author":"Brotman","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0021-9150(87)90117-1","article-title":"Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids","volume":"63","author":"Ettinger","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.revmed.2012.12.005_bib0215","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2169\/internalmedicine.49.3161","article-title":"Prospective short-term effects of glucocorticoid treatment on glucose and lipid metabolism in Japanese","volume":"49","author":"Kuroki","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0220","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000314294","article-title":"Management of dyslipidemia in Cushing's syndrome","volume":"92","author":"Greenman","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0230","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kem062","article-title":"Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome","volume":"46","author":"Fardet","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.12.005_bib0235","first-page":"400","article-title":"Exercise prevents cardiometabolic alterations induced by chronic use of glucocorticoids","volume":"93","author":"Pinheiro CH da","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0240","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion","volume":"157","author":"Fardet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0245","first-page":"E317","article-title":"Effects of glucocorticoids on energy metabolism and food intake in humans","volume":"271","author":"Tataranni","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000314272","article-title":"Metabolic syndrome in Cushing's syndrome","volume":"92","author":"Chanson","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0255","doi-asserted-by":"crossref","first-page":"E571","DOI":"10.1152\/ajpendo.00231.2010","article-title":"Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study","volume":"300","author":"Lee","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0260","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1210\/jc.2003-031157","article-title":"Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes","volume":"89","author":"Lundgren","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0265","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI116821","article-title":"Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men","volume":"92","author":"Fried","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2012.12.005_bib0270","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0275","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2012.12.005_bib0280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ajcn\/43.5.758","article-title":"Altered body fat distribution in patients with glucocorticoid treatment and in patients on long-term dialysis","volume":"43","author":"Horber","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.revmed.2012.12.005_bib0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0039-128X(03)00086-2","article-title":"Differential effects of short-term prednisolone treatment on peripheral and abdominal subcutaneous thickness in children assessed by ultrasound","volume":"68","author":"Schou","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.revmed.2012.12.005_bib0290","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0295","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2007.04.018","article-title":"Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study","volume":"57","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0300","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2133.2010.09877.x","article-title":"Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy","volume":"163","author":"Arena","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0305","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.revmed.2012.12.005_bib0310","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2012.12.005_bib0315","article-title":"Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy","author":"Fardet","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejim.2007.09.015","article-title":"Digital photography as an operational tool for assessing corticosteroid-induced lipodystrophy","volume":"19","author":"Fardet","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0325","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0330","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.revmed.2007.06.002","article-title":"Natural history of corticosteroid-induced lipodystrophy: a prospective follow-up of 37\u00a0patients","volume":"28","author":"Fardet","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.005_bib0335","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0340","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.109830","article-title":"Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma","volume":"106","author":"Covar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0345","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2012.12.005_bib0350","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1378\/chest.48.3.287","article-title":"Long term (five or more years) administration of corticosteroids in pulmonary diseases","volume":"48","author":"Shubin","year":"1965","journal-title":"Dis Chest"},{"key":"10.1016\/j.revmed.2012.12.005_bib0355","first-page":"375","article-title":"Corticosteroids: a review with emphasis on complications of prolonged systemic therapy","volume":"62","author":"Truhan","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1016\/j.revmed.2012.12.005_bib0360","first-page":"S37","article-title":"Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans","volume":"14","author":"Williamson","year":"1996","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.revmed.2012.12.005_bib0365","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF03349774","article-title":"Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor","volume":"18","author":"Whitworth","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.revmed.2012.12.005_bib0370","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.revmed.2009.03.009","article-title":"Short-term effect of dietary-sodium intake on arterial blood pressure of patients treated with systemic corticosteroids: a prospective, randomised, crossover study","volume":"30","author":"Fardet","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.005_bib0375","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1440-1681.2001.03584.x","article-title":"Glucocorticoid-induced hypertension: from mouse to man","volume":"28","author":"Whitworth","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0380","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1681\/ASN.2007080911","article-title":"A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension","volume":"19","author":"Goodwin","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0385","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0960-0760(92)90077-V","article-title":"Glucocorticoid-dependent hypertension","volume":"43","author":"Mantero","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0390","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ecl.2011.01.010","article-title":"How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids","volume":"40","author":"Ong","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.revmed.2012.12.005_bib0395","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/IBPC.S9486","article-title":"Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review","volume":"4","author":"Peppa","year":"2011","journal-title":"Integr Blood Press Control"},{"key":"10.1016\/j.revmed.2012.12.005_bib0400","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0895-7061(95)00149-J","article-title":"Glucocorticoid-induced hypertension in the elderly. Relation to serum calcium and family history of essential hypertension","volume":"8","author":"Sato","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.revmed.2012.12.005_bib0405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/FPC.0b013e3282fc5801","article-title":"Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia","volume":"18","author":"Kamdem","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.revmed.2012.12.005_bib0410","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004872-198907000-00005","article-title":"The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume","volume":"7","author":"Whitworth","year":"1989","journal-title":"J Hypertens"},{"key":"10.1016\/j.revmed.2012.12.005_bib0415","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.revmed.2008.04.001","article-title":"Long-term systemic corticosteroid-therapy associated measures: description of the French internal medicine physicians\u2019 practices","volume":"29","author":"Fardet","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.12.005_bib0420","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jcem-72-5-1060","article-title":"Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor","volume":"72","author":"Montrella-Waybill","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1358\/mf.1998.20.2.472459","article-title":"Losartan in Cushing's syndrome","volume":"20","author":"Zacharieva","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0430","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1358\/mf.1998.20.5.485705","article-title":"Trandolapril in Cushing's disease: short-term trandolapril treatment in patients with Cushing's disease and essential hypertension","volume":"20","author":"Zacharieva","year":"1998","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000314349","article-title":"Coagulopathy in Cushing's syndrome","volume":"92","author":"Trementino","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.revmed.2012.12.005_bib0440","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.revmed.2012.12.005_bib0445","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2006.05.019","article-title":"Use of oral corticosteroids and the risk of acute myocardial infarction","volume":"192","author":"Varas-Lorenzo","year":"2007","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.revmed.2012.12.005_bib0450","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0455","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.166.9.1016","article-title":"Corticosteroids and the risk of atrial fibrillation","volume":"166","author":"van der Hooft","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2012.12.005_bib0460","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","article-title":"The metabolic syndrome and cardiovascular risk in Cushing's syndrome","volume":"34","author":"Pivonello","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.revmed.2012.12.005_bib0470","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008\u00a0expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0475","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1210\/jc.2009-1412","article-title":"11Beta-hydroxysteroid dehydrogenase type 1\u00a0and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0480","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2009.09.024","article-title":"Obesity and corticosteroids: 11beta-hydroxysteroid type 1\u00a0as a cause and therapeutic target in metabolic disease","volume":"316","author":"Morton","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0485","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1367.012","article-title":"Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1\u00a0and metabolic disease","volume":"1083","author":"Walker","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2012.12.005_bib0490","first-page":"1608","article-title":"Reduction of obesity-related metabolic risk by modulating tissue exposition to cortisol","volume":"6","author":"Iovino","year":"2010","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.revmed.2012.12.005_bib0495","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsbmb.2010.02.024","article-title":"Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue","volume":"122","author":"Veilleux","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.revmed.2012.12.005_bib0500","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","article-title":"Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis","volume":"94","author":"Anagnostis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2012.12.005_bib0505","doi-asserted-by":"crossref","first-page":"e8475","DOI":"10.1371\/journal.pone.0008475","article-title":"Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1\u00a0in normal weight postmenopausal women","volume":"4","author":"Andersson","year":"2009","journal-title":"PLoS One"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312011824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:28Z","timestamp":1759336288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312011824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0248866312011824"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effets ind\u00e9sirables m\u00e9taboliques et cardiovasculaires des corticoth\u00e9rapies syst\u00e9miques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}